Wantstats
Company ProfilePremium

Smith & Nephew

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Smith & Nephew - Healthcare showcase

Year Founded & Workforce

1856

15,000 Employees

Industry

Healthcare

Services

Orthopedic ReconstructionRobotics AssistanceWound Management
S

Smith & Nephew Employee Contacts

252 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Smith & Nephew Overview

Company Headquarter: London, UK

Founded: 1856

Workforce: 15000 employees

Company Working: Smith & Nephew develops and markets medical devices worldwide. The company operates through four segments, namely, sports medicine, trauma, orthopedic reconstruction, and advanced wound management. The company primarily serves the providers of medical and surgical treatments and services. In 2014, Smith & Nephew acquired ArthroCare to broaden its sports medicine segment. The company has also acquired Healthpoint Biotherapeutics, which specializes in the production of bioactive for advanced wound management. Smith & Nephew has its presence in more than 100 countries and has major manufacturing units in the US, the UK, Switzerland, Germany, and China.

Strategy

Smith & Nephew strategizes to research, develop, manufacture, and market products which are technologically advanced and innovative. It also focuses on winning in established markets, accelerating development in emerging markets, innovating for value, simplifying and improving the operating model, and supplementing organic growth through acquisitions.

Company Snapshot

$4,669M

Revenue

15,000

Employees

1856

Founded

SWOT Analysis

Strengths

  • Leadership in advanced wound management
  • Consistency in sales which maintains the financial position
  • Worldwide operations
  • Strong brand equity
  • Stable cash flow
  • Large customer base
  • Strong product portfolio
  • The company has a strong global manufacturing facility
  • Focused on R&D programmes and investments in product and technology acquisitions
  • To drive innovation, Smith & Nephew invested around 5% of its revenue in R&D
  • Presence in key markets

Weaknesses

  • Low market capitalization compared to competitors
  • Controversies regarding allegations of corruption against the US and German subsidiaries
  • Risk management process
  • Unstable internal matters
  • The company has low to moderate tolerance towards managing suppliers and facilities
  • Low to moderate tolerance for cyber security risk
  • Instable internal matters

Opportunities

  • Growth through acquisitions
  • Create sustainable business in emerging markets
  • Entering emerging countries
  • Broadening product portfolio
  • Supplement organic growth with acquisitions
  • Improving execution to accelerate organic performance
  • Transforming the business through enabling technologies such as robotics, imaging, and augmented reality
  • Entering the emerging countries

Threats

  • Changing competitive landscape
  • Fluctuating economies
  • New government regulations
  • Insufficient long-term planning
  • Low value business segment investment such as product maintenance and line extension projects
  • Global political uncertainty regarding trade policy
  • New government regulation

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
December 2019AcquisitionSmith & Nephew PLC acquired Osiris Therapeutics, Inc., a US-based company researching, developing, and marketing regenerative medicine products. The acquisition was aimed to accelerate growth from Smith & Nephew’s Advanced Wound Management franchise.
June 2019Product LaunchSmith & Nephew launched PICO 14 single-use negative pressure wound therapy system and presented new evidence to help improve outcomes in hard to heal wounds. The product was introduced at the European Wound Management Association conference, Gothenburg, Sweden.
October 2017Product LaunchSmith & Nephew announced the European launch of handheld imaging technology, heralding a new era of evidence-based decision making in wound care. It can measure the wound surface area and visualizes the presence and distribution of potentially harmful bacteria in wounds.
July 2017CollaborationSmith & Nephew and the University of Hull entered into a long-term collaboration for research on advanced wound care. The partnership creates one of the world’s largest Wound Care Research Clusters, combining world-leading academia and industry to develop scientific insights and innovative treatments for advanced wound care.
March 2019Product LaunchSmith & Nephew launched a multi-asset digital surgery and robotic ecosystem. This platform reduces physical footprint, which makes it an ideal solution for surgical settings, including ambulatory surgical centers.
December 2017Product LaunchSmith & Nephew launched the first robotics-assisted bicruciate retaining total knee replacement procedures.
June 2017Product LaunchSmith & Nephew launched its NAVIO handheld robotics-assisted total knee arthroplasty (TKA) application. With this, it expanded the NAVIO platform to total knees, which comprises 80% of all knee replacement surgeries globally.

Product Offering

  • Smith & Nephew
    • Orthopedic Reconstruction
    • Robotics Assistance
    • Wound Management

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 4,669 Mn in 2016 to USD 4,904 Mn in 2018.
Smith & Nephew — By Business Segment
Series (USD Mn)201620172018
Sales4,6694,7654,904

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →